Paul Chevalier

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors

A. Craig Lockhart, Mace L. Rothenberg, Jakob Dupont et al. · Journal of Clinical Oncology · 2009 · 235 citations · Full text

A phase I dose escalation and pharmacokinetic (PK) study of intravenous (iv) aflibercept (VEGF Trap) plus docetaxel (D) and cisplatin (C) in patients (pts) with advanced solid tumors: preliminary results

G. Freyer, P. Fumoleau, Benoît You et al. · Journal of Clinical Oncology · 2008 · 44 citations

Vegf Trap, Immunology, Pharmacotherapy +19

Pharmacokinetics of Quinupristin-Dalfopristin in Continuous Ambulatory Peritoneal Dialysis Patients

Curtis A. Johnson, Claude A. Taylor, Stephen W. Zimmerman et al. · Antimicrobial Agents and Chemotherapy · 1999 · 34 citations · Full text

Stimulatory effect of a specific substance P antagonist (RPR 100893) of the human NK1 receptor on the estradiol-induced LH and FSH surges in the ovariectomized cynomolgus monkey

Bernard Kerdelhu�, Keith Gordon, Robert F. Williams et al. · Journal of Neuroscience Research · 1997 · 16 citations

Nk1 Receptor Antagonist, Nk1 Receptor, Stimulatory Effect +14

Pharmacokinetics of Quinupristin/ Dalfopristin in Patients with Severe Chronic Renal Insufficiency

Paul Chevalier, Jacques Rey, Oliver Pasquier et al. · Clinical Pharmacokinetics · 2000 · 15 citations

Urology, Renal Function, Medicine +9